Analysis Before and After COVID 19 | NCT04748614

Studies
Analysis Before and After COVID 19

NCT04748614

Sponsor

Kocaeli Derince Education and Research Hospital

Status

Unknown status

Last Update Posted

Feb 10, 2021Actual

Enrollment

500Estimated

Phase

Not provided

Conditions

Cost of ICU

Interventions

Cost

Countries

Not provided

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Feb 2021

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Not yet recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Feb 15, 2021Estimated

Primary Completion Date

Mar 15, 2021Estimated

Completion Date

Mar 30, 2021Estimated

First Submitted Date

Feb 8, 2021

First Submission Date that Met QC Criteria

Feb 8, 2021

First Posted Date

Feb 10, 2021Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Feb 8, 2021

Last Update Posted Date

Feb 10, 2021Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

Merve Yazici Kara, MD, Kocaeli Derince Education and Research HospitalPrincipal Investigator

Lead Sponsor

Kocaeli Derince Education and Research HospitalOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

In our study, we aimed to compare the average length of stay, death rates and costs of intensive care patients in October-November-December 2019 (before COVID 19) and October-November-December 2020 (during COVID 19).

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

500Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Before SARS-Cov2		Before SARS-Cov2	Other: Cost
After SARS-Cov2		After SARS-Cov2	Other: Cost

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Cost	Other	ICU cost	After SARS-Cov2 Before SARS-Cov2

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Cost of ICU	Cost of ICU	1 month

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Above 18 years old
All patients in intensive care unit in last three months of 2019
All SARS-Cov2 patients in intensive care unit in last three months of 2020

Exclusion Criteria:

Under 18 years old

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

All patients hospitalized in intensive care in the last 3 months of 2019 and all SARS-Cov2 patients hospitalized in intensive care in the last 3 months of 2020.

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Ilke Kupeli	Contact	+90 555 548 5632		ilkeser2004@gmail.com

Overall Officials

Not provided

Locations

Not provided

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
33348933	Result	Khan AA, AlRuthia Y, Balkhi B, Alghadeer SM, Temsah MH, Althunayyan SM, Alsofayan YM. Erratum: Khan, A.A., et al. Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia (Short Title: COVID-19 Survival and Cost in Saudi Arabia). Int. J. Environ. Res. Public Health 2020, 17, 7458. Int J Environ Res Public Health. 2020 Dec 17;17(24):9458. doi: 10.3390/ijerph17249458.

ID	Term
D004467	Economics
D004472	Health Care Economics and Organizations